Design of Biomedical Robots for the Analysis of Cancer, Neurodegenerative and Rare Diseases

  • Juan L. Fernández-Martínez
  • Enrique J. deAndrés-Galiana
  • Stephen T. Sonis
Conference paper
Part of the Advances in Intelligent Systems and Computing book series (AISC, volume 391)


Studies of genomics make use of high throughput technology to discover and characterize genes associated with cancer and other illnesses. Genomics may be of particular value in discovering mechanisms and interventions for neurodegenerative and rare diseases in the quest for orphan drugs. To expedite risk prediction, mechanism of action and drug discovery, effectively, analytical methods, especially those that translate to clinical relevant outcomes, are highly important. In this paper, we define the term biomedical robot as a novel tool for genomic analysis in order to improve phenotype prediction, identifying disease pathogenesis and significantly defining therapeutic targets. The implementation of a biomedical robot in genomic analysis is based on the use of feature selection methods and ensemble learning techniques. Mathematically, a biomedical robot exploits the structure of the uncertainty space of any classification problem conceived as in an ill-posed optimization problem, that is, given a classifier several equivalent low scale signatures exist providing similar prediction accuracies. As an example, we applied this method to the analysis of three different expression microarrays publically available concerning Chronic Lymphocytic Leukemia, Inclusion Body Myositis/Polimyositis (IBM-PM) and Amyotrophic Lateral Sclerosis (ALS). Using these examples we showed the value of the biomedical robot concept to improve knowledge discovery and provide decision systems in order to optimize diagnosis, treatment and prognosis. The goal of the FINISTERRAE project is to leverage publically available genetic databases of rare and neurodegenerative diseases and construct a relational database with the genes and genetic pathways involved, which can be used to accelerate translational research in this domain.


Biomedical robots Genomics Cancer Rare and Neurogenerative diseases 


  1. 1.
    Fernández-Martínez, J.L., Luaces, O., del Coz, J., Fernández, R., Solano, J., Nogués, E., Zanabilli, Y., Alonso, J., Payer, A., Vicente, J., et al.: On the prediction of Hodgkin lymphoma treatment response. In: Clinical and Translational Oncology, pp. 1–8 (2015)Google Scholar
  2. 2.
    Fernández-Martínez, J.L., Fernandez Muniz, M.Z., Tompkins, M.J.: On the topography of the cost functional in linear and nonlinear inverse problems. Geophysics 77(1), W1–W15 (2012)Google Scholar
  3. 3.
    Fernández-Martínez, J.L., Cernea, A.: Exploring the uncertainty space of ensemble classifiers in face recognition. Int. J. Pattern Recognit. Artif. Intell. 29(03), 1556002 (2015)CrossRefGoogle Scholar
  4. 4.
    Fernández-Martínez, J.L., Fernández-Muñiz, Z., Pallero, J., Pedruelo-González, L.M.: From Bayes to tarantola: new insights to understand uncertainty in inverse problems. J. Appl. Geophys. 98, 62–72 (2013)CrossRefGoogle Scholar
  5. 5.
    Fernández-Martínez, J.L., Pallero, J., Fernández-Muñiz, Z., Pedruelo-González, L.M.: The effect of noise and Tikhonov regularization in inverse problems. Part II: the nonlinear case. J. Appl. Geophys. 108, 186–193 (2014)CrossRefGoogle Scholar
  6. 6.
    Fernández-Martínez, J.L., Pallero, J.L.G., Fernandez-Muniz, Z.: The effect of noise and tikhonov regularization in inverse problems. Part I: the linear case. J. Appl. Geophys. 108, 176–185 (2014)CrossRefGoogle Scholar
  7. 7.
    Ferreira, P.G., Jares, P., Rico, D., Gómez-López, G., Martínez-Trillos, A., Villamor, N., Ecker, S., González-Pérez, A., Knowles, D.G., Monlong, J., et al.: Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res. 24(2), 212–226 (2014)CrossRefGoogle Scholar
  8. 8.
    Greenberg, S., Bradshaw, E., Pinkus, J., Pinkus, G., Burleson, T., et al.: Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 65(11), 1782–1787 (2005)CrossRefGoogle Scholar
  9. 9.
    Lincecum, J.M., Vieira, F.G., Wang, M.Z., Thompson, K., De Zutter, G.S., et al.: From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nature Genet. 42(5), 392–399 (2010)CrossRefGoogle Scholar
  10. 10.
    National Institute of Neurological Disorders and Stroke: Motor neuron diseases. Fact Sheet (2010)Google Scholar
  11. 11.
    Pawitan, Y., Ploner, A.: OCplus: Operating characteristics plus sample size and local FDR for microarray experiments, R package, version 1.40.0Google Scholar
  12. 12.
    Saligan, L.N., Fernández-Martínez, J.L., et al.: Supervised classification by filter methods and recursive feature elimination predicts risk of radiotherapy-related fatigue in patients with prostate cancer. Cancer Inform. 13, 141–152 (2014)CrossRefGoogle Scholar
  13. 13.
    Strausberg, R.L., Simpson, A.J., Old, L.J., Riggins, G.J.: Oncogenomics and the development of new cancer therapies. Nature 429(6990), 469–474 (2004)CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Juan L. Fernández-Martínez
    • 1
  • Enrique J. deAndrés-Galiana
    • 1
    • 2
  • Stephen T. Sonis
    • 3
  1. 1.Mathematics DepartmentUniversity of OviedoAsturiasSpain
  2. 2.Artificial Intelligence Centre, Machine Learning GroupUniversity of OviedoAsturiasSpain
  3. 3.Biomodels LLCWatertownUSA

Personalised recommendations